Outset Medical (OM) Return on Invested Capital (2021 - 2025)
Outset Medical (OM) has disclosed Return on Invested Capital for 5 consecutive years, with 0.07% as the latest value for Q4 2025.
- On a quarterly basis, Return on Invested Capital rose 41.0% to 0.07% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.07%, a 41.0% increase, with the full-year FY2025 number at 0.08%, up 40.0% from a year prior.
- Return on Invested Capital was 0.07% for Q4 2025 at Outset Medical, up from 0.29% in the prior quarter.
- In the past five years, Return on Invested Capital ranged from a high of 0.07% in Q4 2025 to a low of 0.67% in Q4 2023.
- A 5-year average of 0.43% and a median of 0.48% in 2024 define the central range for Return on Invested Capital.
- Peak YoY movement for Return on Invested Capital: fell -23bps in 2022, then soared 41bps in 2025.
- Outset Medical's Return on Invested Capital stood at 0.31% in 2021, then plummeted by -59bps to 0.49% in 2022, then crashed by -36bps to 0.67% in 2023, then increased by 28bps to 0.48% in 2024, then skyrocketed by 85bps to 0.07% in 2025.
- Per Business Quant, the three most recent readings for OM's Return on Invested Capital are 0.07% (Q4 2025), 0.29% (Q3 2025), and 0.3% (Q2 2025).